Form 8-K - Current report:
SEC Accession No. 0001213900-19-002029
Filing Date
2019-02-11
Accepted
2019-02-11 08:00:34
Documents
1
Period of Report
2019-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k020519_relmadatherap.htm 8-K 17617
  Complete submission text file 0001213900-19-002029.txt   18760
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-55347 | Film No.: 19581928
SIC: 2834 Pharmaceutical Preparations